Skip to main content
Fig. 1 | Journal of Pharmaceutical Health Care and Sciences

Fig. 1

From: Antiemetic efficacy and safety of granisetron or palonosetron alone and in combination with a corticosteroid for ABVD therapy-induced nausea and vomiting

Fig. 1

Complete control by phase. The bar shows the percentage of patients achieving complete control (CC) during the acute (0–24 h after initiation of chemotherapy), delayed (24–120 h) and overall phases. CC was defined as no vomiting and no use of antiemetic rescue medication with only grade 0–1 nausea. White and black bars represent the granisetron- and palonosetron-based antiemetic regimens, respectively

Back to article page

Journal of Pharmaceutical Health Care and Sciences

ISSN: 2055-0294

Contact us